Stocks
Novartis (NVS) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 6.10 | 0.63 | 0.68 | 10.3 | 12.7 | 14.7 | ||
| Changes by years, y/y, % | -54% | -90% | +7% | +1 425% | +23% | -0.9% | |||
Novartis. EV/EBITDA
Novartis. EV/EBITDA, changes, %
Novartis (NVS) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | 11.1 | 11.5 | 11.4 | 12.7 | 14.8 | 14.7 | |
| Changes by years, y/y, % | +1 059% | +963% | -10% | +24% | +33% | |||
| Changes by quarters, q/q, % | +9% | +3% | -1% | +11% | +17% | |||
